Results 11 - 20 of 1609 : Previous 1 2 3 4 5 6 7 8 9 Next
Bristol-Myers Squibb Meets on the Top Line, Misses Where it Counts
Just the facts, Fool.
Is Bristol-Myers Squibb a Buffett Stock?
Let's find out.
19 Clinical Trials Aren't Enough
The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin.
This High-Yield Portfolio Will Beat the Market
48 weeks in and my dividend picks are already beating the market.
Buying on Bad News: Can These Dividend Stocks Weather More Volatility?
Are any of these names in your portfolio -- or on your watchlist?
2 High-Flying Biotechs Face a New Hurdle
Comparing clinical trials can be difficult.
Pharma Focus Is Good For Your Portfolio
Build your own portfolio.
CEO Gaffe of the Week: Bristol-Myers Squibb
Some days, CEOs would be better off staying in bed.
Finding out which companies will reward investors the most.